论文部分内容阅读
目的探讨善宁治疗重症胰腺炎的临床疗效。方法将50例重症胰腺炎患者随机分成治疗组和对照组各25例,对照组进行常规治疗,治疗组在常规治疗基础上加用善宁,观察两组治疗前后血清淀粉酶含量变化,分析有效率和病死率之间的差别。结果治疗组的血清淀粉酶下降明显低于对照组(P<0.05),有效率高于对照组(P<0.05),病死率低于对照组(P<0.01)。结论善宁能有效降低重症胰腺炎患者的血清淀粉酶含量,提高患者的生存率。
Objective To investigate the clinical effect of Shanning on severe pancreatitis. Methods 50 cases of severe pancreatitis were randomly divided into treatment group and control group of 25 cases, the control group for routine treatment, the treatment group on the basis of conventional treatment with the use of good Ning, observed before and after treatment, serum amylase content changes, analysis of The difference between efficiency and fatality. Results The decrease of serum amylase in the treatment group was significantly lower than that in the control group (P <0.05), and the effective rate was higher than that of the control group (P <0.05). The mortality was lower than that of the control group (P <0.01). Conclusion Sunning can effectively reduce the serum amylase content of patients with severe pancreatitis and improve the survival rate of patients.